UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P652: IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BETWEEN 1998‐2022, INCLUDING THE ERA OF TARGET THERAPIES WITH BCL2 AND BTK INHIBITORS

HemaSphere, 2023-08, Vol.7 (S3), p.e944666d-n/a

2023

Volltextzugriff (PDF)

P1532: CLINICAL OUTCOMES OF COVID‐19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)

HemaSphere, 2023-08, Vol.7 (S3), p.e96550ad-n/a

2023

Volltextzugriff (PDF)

Chronic Lymphocytic Leukemia: Novel Perspectives - How to Teach an Old Dog New Tricks

Acta haematologica, 2024-01, Vol.147 (1), p.5-7

2024

Volltextzugriff (PDF)

P651: REAL‐WORLD EFFECTIVENESS OF VENETOCLAX‐BASED REGIMENS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN ISRAEL: UPDATE FROM THE MULTICENTER PROSPECTIVE REVEAL STUDY

HemaSphere, 2023-08, Vol.7 (S3), p.e4428024-n/a

2023

Volltextzugriff (PDF)

Effectiveness of nirmatrelvir plus ritonavir treatment for patients with CLL during the Omicron Surge

Blood, 2023-02

2023

Volltextzugriff (PDF)

Health-Related Quality of Life in Chronic Lymphocytic Leukemia Patients in Active Surveillance and Active Treatment in Israel

Blood, 2023-11, Vol.142 (Supplement 1), p.6525-6525

2023

Volltextzugriff (PDF)

INTEGRATIVE MEDICINE AND CHRONIC LYMPHOCYTIC LEUKEMIA

הרפואה, 2017-02, Vol.156 (2), p.89

Tadmor, Tamar

2017

Volltextzugriff (PDF)

HEPATIC MANIFESTATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND CORRELATION WITH PROGNOSIS

הרפואה, 2023-03, Vol.162 (3), p.136

2023

Volltextzugriff (PDF)

A Prospective, Phase-II Study to Evaluate the Efficacy and Safety of Obinutuzumab, Ibrutinib, and Venetoclax (GIVeRS) in Patients with Richter's Syndrome

Blood, 2023-11, Vol.142 (Supplement 1), p.4640-4640

2023

Volltextzugriff (PDF)

Intake of Proton Pump Inhibitors Is Associated with a Shorter Time to First Treatment in Early-Stage Chronic Lymphocytic Leukemia

Acta haematologica, 2024-09, p.1-7

2024

Volltextzugriff (PDF)

Efficacy of Preexposure Prophylaxis with Monoclonal-Antibody AZD7442 (tixagevimab-cilgavimab) Against Sars-Cov-2 Variants in Patients with CLL

Blood, 2022-11, Vol.140 (Supplement 1), p.9900-9901

2022

Volltextzugriff (PDF)

Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphoma-possible link with monocytic myeloid-derived suppressor cells

Hematological oncology, 2013-06, Vol.31 (2), p.65-71

2013

Volltextzugriff (PDF)

The Involvement of LAG3+ Plasma Cells in the Development of Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.7112-7113

2022

Volltextzugriff (PDF)

Phase 3 BELLWAVE-011 Study: Nemtabrutinib Versus Ibrutinib or Acalabrutinib in Previously Untreated Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL)

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S182-S182

2024

Volltextzugriff (PDF)

CLL-414 Phase 3 BELLWAVE-011 Study: Nemtabrutinib Versus Ibrutinib or Acalabrutinib in Previously Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S352-S353

2024

Volltextzugriff (PDF)

The Involvement of LAG-3[sup.positive] Plasma Cells in the Development of Multiple Myeloma

International journal of molecular sciences, 2023-12, Vol.25 (1)

2023

Volltextzugriff (PDF)

Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.638-638

2021

Volltextzugriff (PDF)

Shiga-like Toxin Producing E. coli Identified in Patients with Multiple Myeloma (MM) Hospitalized Due to Acute Onset Diarrhea; First Report on the Clinical Use of the Biofire Film Array Gastrointestinal Panel

Blood, 2018-11, Vol.132 (Supplement 1), p.4959-4959

2018

Volltextzugriff (PDF)

Utilization of Antifungal Prophylaxis and Treatment for Newly Diagnosed AML Patients Treated with Venetoclax Based Regimens in Routine Clinical Practice - a Prospective Analysis from the Revive Study

Blood, 2022-11, Vol.140 (Supplement 1), p.6162-6164

2022

Volltextzugriff (PDF)

Clinical Predictors for Relapse Among Patients with AML Who Responded to Venetoclax-Based Treatment - a Real-World Prospective Analysis from the Revive Study Group

Blood, 2022-11, Vol.140 (Supplement 1), p.9002-9004

2022

Volltextzugriff (PDF)

Supplement of Vitamin D for early-stage Chronic Lymphocytic Leukemia Patients is Associated with a Longer Time to first Treatment

Blood advances, 2024-05

2024

Volltextzugriff (PDF)

The Role of Alpha 2 Macroglobulin in Chronic Activation of the Complement System in Patients with Chronic Lymphocytic Leukemia

Blood, 2020-11, Vol.136 (Supplement 1), p.17-17

2020

Volltextzugriff (PDF)

Clinical & Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical Practice in Israel

Blood, 2020-11, Vol.136 (Supplement 1), p.23-24

2020

Volltextzugriff (PDF)

Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia

Blood, 2020-11, Vol.136 (Supplement 1), p.40-40

2020

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(102)
Hebräisch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

P652: IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BETWEEN 1998‐2022, INCLUDING THE ERA OF TARGET THERAPIES WITH BCL2 AND BTK INHIBITORS

P1532: CLINICAL OUTCOMES OF COVID‐19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)

Chronic Lymphocytic Leukemia: Novel Perspectives - How to Teach an Old Dog New Tricks

P651: REAL‐WORLD EFFECTIVENESS OF VENETOCLAX‐BASED REGIMENS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN ISRAEL: UPDATE FROM THE MULTICENTER PROSPECTIVE REVEAL STUDY

P1208: TRANSCRIPTOMIC PROFILING OF B CELL STATES AND MICROENVIROMENTAL ECOSYSTEMS REFINES THE PROGNOSTIC CLASSIFICATION OF DIFFUSE LARGE B CELL LYMPHOMA

Effectiveness of nirmatrelvir plus ritonavir treatment for patients with CLL during the Omicron Surge

Health-Related Quality of Life in Chronic Lymphocytic Leukemia Patients in Active Surveillance and Active Treatment in Israel

INTEGRATIVE MEDICINE AND CHRONIC LYMPHOCYTIC LEUKEMIA

HEPATIC MANIFESTATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND CORRELATION WITH PROGNOSIS

A Prospective, Phase-II Study to Evaluate the Efficacy and Safety of Obinutuzumab, Ibrutinib, and Venetoclax (GIVeRS) in Patients with Richter's Syndrome

Intake of Proton Pump Inhibitors Is Associated with a Shorter Time to First Treatment in Early-Stage Chronic Lymphocytic Leukemia

Efficacy of Preexposure Prophylaxis with Monoclonal-Antibody AZD7442 (tixagevimab-cilgavimab) Against Sars-Cov-2 Variants in Patients with CLL

Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphoma-possible link with monocytic myeloid-derived suppressor cells

The Involvement of LAG3+ Plasma Cells in the Development of Multiple Myeloma

Phase 3 BELLWAVE-011 Study: Nemtabrutinib Versus Ibrutinib or Acalabrutinib in Previously Untreated Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL)

CLL-414 Phase 3 BELLWAVE-011 Study: Nemtabrutinib Versus Ibrutinib or Acalabrutinib in Previously Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

The Involvement of LAG-3[sup.positive] Plasma Cells in the Development of Multiple Myeloma

Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia

Shiga-like Toxin Producing E. coli Identified in Patients with Multiple Myeloma (MM) Hospitalized Due to Acute Onset Diarrhea; First Report on the Clinical Use of the Biofire Film Array Gastrointestinal Panel

Utilization of Antifungal Prophylaxis and Treatment for Newly Diagnosed AML Patients Treated with Venetoclax Based Regimens in Routine Clinical Practice - a Prospective Analysis from the Revive Study

Clinical Predictors for Relapse Among Patients with AML Who Responded to Venetoclax-Based Treatment - a Real-World Prospective Analysis from the Revive Study Group

Supplement of Vitamin D for early-stage Chronic Lymphocytic Leukemia Patients is Associated with a Longer Time to first Treatment

The Role of Alpha 2 Macroglobulin in Chronic Activation of the Complement System in Patients with Chronic Lymphocytic Leukemia

Clinical & Economic Implications of Hydroxyurea Intolerance in Polycythemia Vera in Routine Clinical Practice in Israel

Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia

Aktive Filter

Suchergebnisse filtern